Pure Global
NCT04816539

Comparison of the TOFscan and the TetraGraph During Recovery of Neuromuscular Function

Comparison of the TOFscan and the TetraGraph During Recovery of Neuromuscular Function : a Pilot Study
Central Hospital, Nancy, France·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Neuromuscular Blockade
Drug/Device/Intervention
TetraGraph
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Central Hospital, Nancy, France
Location
Vandœuvre-lès-Nancy, France
Timeline & enrollment
Phase
N/A
Start date
Apr 15, 2021
End date
Apr 30, 2021
Enrollment
20 participants
Primary outcome

Train-of-four ratios

Summary

Assess the values of train-of-four ratios with the TetraGraph and thoses obtained with the
 TOFscan during recovery of neuromusculat function in surgical patients who have been
 administred rocuronium.
 
 Primary outcome : value of TOFratio with the TetraGraph when TOFratio of TOFscan is greater
 than or equal to 90% Pilot study : no hypothesis

ICD-10 classifications
Skeletal muscle relaxants [neuromuscular blocking agents]Poisoning: Skeletal muscle relaxants [neuromuscular blocking agents]Other neuromuscular dysfunction of bladderNeuromuscular dysfunction of bladder, unspecifiedNeuromuscular scoliosis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04816539
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT04816539 through Pure Global AI's free database. This phase not specified trial is sponsored by Central Hospital, Nancy, France and is currently Not yet recruiting. The study focuses on Neuromuscular Blockade. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.